This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2003-2007.
Company Filing History:
Years Active: 2003-2007
Title: Gerd-Ulfert Heese: Innovator in Pharmaceutical Development
Introduction
Gerd-Ulfert Heese is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable drug formulations. His work has led to the filing of multiple patents, showcasing his innovative approach to drug delivery systems.
Latest Patents
Gerd-Ulfert Heese holds 2 patents that focus on the creation of stable drug forms for oral administration. His latest patents include a stable drug form for oral administration with benzimidazole derivatives as the active ingredient. This invention relates to a stable medicament designed for oral use, along with a method for its production.
Career Highlights
Heese is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on groundbreaking projects that aim to improve patient outcomes through innovative drug formulations.
Collaborations
Throughout his career, Gerd-Ulfert Heese has collaborated with esteemed colleagues such as Arnim Laicher and Claudio Lorck. These partnerships have further enhanced the quality and impact of his work in the pharmaceutical industry.
Conclusion
Gerd-Ulfert Heese is a prominent figure in pharmaceutical innovation, with a focus on developing stable drug formulations. His contributions through patents and collaborations continue to influence the field and improve therapeutic options for patients.